| Date Filed | Type | Description |
| 02/28/2023 |
4
| Yonehiro Grant (Chief Business Officer) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Granted 228,000 options to buy
@ $1.59, valued at
$362.5k
|
|
| 02/28/2023 |
4
| Schatzman Randall C (CEO) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Granted 728,270 options to buy
@ $1.59, valued at
$1.2M
|
|
| 02/28/2023 |
4
| Perez Edith A. (Chief Medical Officer) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $1.59, valued at
$397.5k
|
|
| 02/28/2023 |
4
| Quinn William P. (CFO) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $1.59, valued at
$397.5k
|
|
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| O'CALLAGHAN BRIAN (Director) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.99, valued at
$49.8k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2022 |
4
| O'CALLAGHAN BRIAN (Director) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Granted 22,140 options to buy
@ $3.03, valued at
$67.1k
Granted 14,071 options to buy
@ $3.03, valued at
$42.6k
|
|
| 03/28/2022 |
4
| LAPORTE KATHLEEN (Director) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $3.03, valued at
$75.8k
|
|
| 03/28/2022 |
4
| Lee Frank D. (Director) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Granted 22,140 options to buy
@ $3.03, valued at
$67.1k
Granted 14,071 options to buy
@ $3.03, valued at
$42.6k
|
|
| 03/28/2022 |
4
| ENGLEMAN EDGAR (Director) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $3.03, valued at
$75.8k
|
|
| 03/28/2022 |
4
| ONETTO NICOLE (Director) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Granted 22,140 options to buy
@ $3.03, valued at
$67.1k
Granted 12,227 options to buy
@ $3.03, valued at
$37k
|
|
| 03/28/2022 |
4
| MILLER RICHARD A MD (Director) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $3.03, valued at
$75.8k
|
|
| 03/28/2022 |
4
| SHAH MAHENDRA (Director) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $3.03, valued at
$75.8k
|
|
| 03/28/2022 |
4
| HEALY JAMES (Director) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $3.03, valued at
$75.8k
|
|
| 02/23/2022 |
4
| Perez Edith A. (Chief Medical Officer) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Granted 210,000 options to buy
@ $3.08, valued at
$646.8k
|
|
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Quinn William P. (CFO) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Granted 210,000 options to buy
@ $3.08, valued at
$646.8k
|
|
| 02/23/2022 |
4
| Dornan David (Chief Scientific Officer) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Granted 210,000 options to buy
@ $3.08, valued at
$646.8k
|
|
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2022 |
4
| Perez Edith A. (Chief Medical Officer) has filed a Form 4 on Bolt Biotherapeutics, Inc.|
Txns:
| Bought 917 shares
@ $16.65, valued at
$15.3k
Bought 411 shares
@ $4.64, valued at
$1.9k
Exercised 35,714 options to buy
@ $2.8, valued at
$100k
|
|
| 12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|